Table 1.
Demographics and clinical characteristics of study cohort.
| NA | PST | PA | p* | |
|---|---|---|---|---|
| Total number | 12 | 12 | 12 | |
| Sex: male, n (%) | 5 (42%) | 7 (58%) | 8 (67%) | 0.59 |
| Both parents born in Australia, n (%) | 11 (92%) | 8 (67%) | 5 (42%) | 0.04 |
| Family history of allergya, n (%) | 9 (75%) | 9 (75%) | 8 (67%) | 1 |
| Eczema at age 1 yearb, n (%) | 4 (33%) | 6 (50%) | 5 (42%) | 0.91 |
| Peanut SPT (mm), median (IQR) | 0 (0) | 3.25 (1.38) | 9.0 (2.0) | 0.0001** |
| Peanut sIgE (kUA/L)c, median (IQR) | 0.005 (0.015) [3 ND] | 1.14 (1.24) | 4.24 (10.54) [3 ND] | 0.11** |
| Egg allergic, (%) | 0 (0%) | 9 (75%) | 10 (83%) | <0.0001 (1**) |
| Sesame allergic | 0 (0%) | 0 (0%) | 0 (0%) | 1 |
| Sensitized to cow’s milkd | 0 (0%) | 1 (8%) | 2 (17%) | 0.45 |
| Sensitized to house dust mited | 0 (0%) | 1 (8%) | 2 (17%) | 0.76 |
IQR interquartile range, ND data not available.
*p-values by Fisher’s exact test between the three groups.
**p-values by Fisher’s exact test or Wilcoxon’s rank-sum test for the comparison between PST and PA.
aAsthma, allergic rhinitis, eczema, or food allergy.
bDoctor diagnosed eczema requiring topical steroid treatment or eczema observed by a trained nurse.
cValues at the lower detection limit of 0.01 kUA/L were set to 0.005.
dSkin prick test ≥2 mm.